METHYLPREDNISOLONE 400 MG/10 ML
METHYLPREDNISOLONE 400 MG/10 ML, a generic anti-inflammatory steroid, has a $6.51 acquisition cost while hospitals typically charge 10-50 times more than wholesale pricing.
About the analyst
Elena Vasquez leads hospital billing pattern analysis at BillRazor Research. She focuses on identifying overcharges, markup outliers, and patient advocacy strategies. Expertise: hospital billing patterns, overcharge analysis, patient advocacy.
METHYLPREDNISOLONE 400 MG/10 ML is an injectable anti-inflammatory steroid used for severe inflammatory conditions and immune system disorders. This generic formulation typically charges 8.2x the Medicare reimbursement rate, with potential billing differences of $2,400 depending on the administration setting.
No credit card required. Results in 60 seconds.
Related pricing data
Data source: National Average Drug Acquisition Cost (NADAC) survey, published by CMS. HCPCS drug pricing codes from Medicare Part B Drug Average Sales Price file.
What NADAC means: The average price pharmacies pay to acquire this drug from wholesalers. Hospital charges for the same drug are typically higher due to facility fees, compounding, and administration costs.
Limitations: NADAC reflects pharmacy acquisition cost, not patient out-of-pocket cost. Insurance copays, formulary tiers, and manufacturer rebates affect what patients actually pay.